Home
Products
Learn
About
Pricing
Log In
Back
NKL
Asset Logo

Nickelx Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-15.11%
Annual Growth

4 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

NickelX Ltd. provides exploration services. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-05-07. The firm is primarily engaged in exploring for high-grade nickel sulfide deposits initially in the Albany Fraser Orogen (AFO). Its projects include Biranup project and Ponton project. Its Biranup project is an early-stage nickel-copper-cobalt and gold project located in the north-eastern Albany-Fraser belt, approximately 350 kilometers (km) north-east of Kalgoorlie. The Ponton project is located approximately 225km east-southeast of Kalgoorlie-Boulder, which consists of one exploration license application covering a total area of 41 square kilometers. The firm also acquire an interest in Cosmos South Nickel Project, which is located approximately 10 km south of the high-grade Cosmos Nickel operations (Western Areas Limited-IGO Limited) and 20km North of the Leinster Nickel operations (BHP- Nickel West), within the prolific Wiluna Greenstone Belt (WGB), Western Australia.

📈 Performance

$0.17

AUD

N/A

31st May 2021, 12:00 a.m.

1M
All Time
GRAPH
TABLE
GRAPH
TABLE
Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.07

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in NKL

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in NKL

N/A
NKL investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in NKL also invest in...

Betashares Nasdaq 100 Etf

NDQ

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

📊 Share price

$34.01 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

Find Out More

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria and currently employs 234 full-time employees. The company went IPO on 2017-11-15. In MTR therapy, a radionuclide is attached to a targeting agent such as a small molecule or antibody. This targeting agent specifically binds to tumors and delivers a radioactive payload in a selective way. The radioactive payload can either be diagnostic (for imaging) or therapeutic, or both. The Company’s lead programs include TLX591-CDx (Illuccix) / TLX591 for diagnosis and treatment of metastatic castrate-resistant prostate cancer, TLX250-CDx/TLX250 for diagnosis and treatment of renal (kidney) cancer, TLX101-CDx / TLX101 for diagnosis and treatment of glioblastoma (brain cancer), and TLX66-CDx (Scintimun) / TLX66 for the treatment of bone marrow conditioning and rare diseases.

📊 Share price

$11.55 AUD

QUAL

QUAL.AX was created on 2014-10-29 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

📊 Share price

$43.79 AUD

NULL GLOBAL

NULL SMART BETA

NULL EX AUSTRALIA

MVW.AX was created on 2014-03-04 by VanEck. The fund's investment portfolio concentrates primarily on large cap equity. MVW.AX invests in a diversified portfolio of ASX-listed securities with the aim of providing investment returns before fees and other costs that track the performance of the MVIS Australia Equal Weight Index

📊 Share price

$34.83 AUD

NULL AUSTRALIA

NULL SMART BETA

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

Want more shares? Try these...

📊 Share price

$0.01 AUD
Compare
Add to watchlist